Editorial

Josef Stehlik, MD, MPH
Section of Heart Failure and Transplantation, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

David O. Taylor, MD
Director, Heart Failure Special Care Unit, The Cleveland Clinic Foundation

Address: David Taylor, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Josef Stehlik, MD, MPH
Section of Heart Failure and Transplantation, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

David O. Taylor, MD
Director, Heart Failure Special Care Unit, The Cleveland Clinic Foundation

Address: David Taylor, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Josef Stehlik, MD, MPH
Section of Heart Failure and Transplantation, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

David O. Taylor, MD
Director, Heart Failure Special Care Unit, The Cleveland Clinic Foundation

Address: David Taylor, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Neil B. Mehta, MD
Department of General Internal Medicine; Director, Center for Online Medical Education and Training, The Cleveland Clinic Foundation

Address: Neil Mehta, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Neil B. Mehta, MD
Department of General Internal Medicine; Director, Center for Online Medical Education and Training, The Cleveland Clinic Foundation

Address: Neil Mehta, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Neil B. Mehta, MD
Department of General Internal Medicine; Director, Center for Online Medical Education and Training, The Cleveland Clinic Foundation

Address: Neil Mehta, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Sherif B. Mossad, MD
Department of Infectious Diseases, The Cleveland Clinic

Address: Sherif B. Mossad, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Sherif B. Mossad, MD
Department of Infectious Diseases, The Cleveland Clinic

Address: Sherif B. Mossad, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Sherif B. Mossad, MD
Department of Infectious Diseases, The Cleveland Clinic

Address: Sherif B. Mossad, MD, Department of Infectious Diseases, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Robert Detrano, MD, PhD
Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, Los Angeles

Address: Robert Detrano, MD, PhD, Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, Torrance, CA 90502

Robert Detrano, MD, PhD
Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, Los Angeles

Address: Robert Detrano, MD, PhD, Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, Torrance, CA 90502

Robert Detrano, MD, PhD
Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, Los Angeles

Address: Robert Detrano, MD, PhD, Division of Cardiology, Department of Medicine, Harbor-UCLA Research and Education Institute, 1124 West Carson Street, Torrance, CA 90502

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.

Gregg C. Fonarow, MD
Director, Ahmanson-UCLA Cardiomyopathy Center; Director, Cardiology Fellowship Training Program; Co-Director, UCLA Preventive Cardiology Program; Associate Professor of Medicine, UCLA Division of Cardiology, Los Angeles

Address: Gregg C. Fonarow, MD, Ahmanson-University of California Los Angeles Cardiomyopathy Center, UCLA Division of Cardiology, 47-123 CHS, UCLA Medical Center, 10833 Le Conte Avenue, Los Angeles, CA 90095-1679; e-mail: [email protected]

The author has indicated that he has received grant or research support from the Bristol-Myers Squibb, Merck, Merck-Schering Plough, and Pfizer corporations, and that he serves as a consultant and is on the speakers’ bureaus of the same corporations.